Last reviewed · How we verify

NCT03624218

Outcomes After Spinal Cord Injury (OASIS)

Completed NA Last updated 23 January 2026
What this trial tests

NA trial testing Prolonged Exposure Therapy in Posttraumatic Stress Disorder in 30 participants. Completed in 6 January 2026.

Timeline
21 February 2018
Primary endpoint
30 March 2021
6 January 2026

Quick facts

Lead sponsorBaylor Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date21 February 2018
Primary completion30 March 2021
Estimated completion6 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor Research Institute

Who can join

18 and older, any sex, with Posttraumatic Stress Disorder or Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study evaluates the effectiveness of Prolonged Exposure Therapy on a population of individuals with spinal cord injuries. Participants will be randomly assigned to either a treatment as usual or Prolonged Exposure therapy group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prolonged exposure therapy for PTSD among spinal cord injury survivors: Study protocol for a randomized controlled trial.
    Powers MB, Pogue JR, Curcio NE, Patel S, et al · · 2021 · cited 2× · PMID 34013091 · DOI 10.1016/j.conctc.2021.100763

Verify or expand the search:

Other trials of Prolonged Exposure Therapy

Trials testing the same drug.

Other recruiting trials for Posttraumatic Stress Disorder

Currently open trials in the same condition.

Other Baylor Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03624218.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing